FDA is Selling the Brooklyn Bridge
This issue is NOT about trial lawyers, this issue is about the rights and health, and safety of ordinary citizens.
Prescription for Disaster–Shift to Medicare leaves Patients Stranded
In what appears to be a re-run of the Katrina rescue disaster–The New York Times front page report provides yet another example of mindless and heartless shot gun public polices that are being tested on a vulnerable population of citizens:
Sec Defense Rumsfeld Tamiflu Holdings
Fortune Magazine confirms our report (October) that "The prospect of a bird flu outbreak may be panicking people around the globe, but it’s proving to be very good news for Defense Secretary."
“this was a drug bill written by and for lobbyists”
Two items in today’s New York Times illustrate the contrast between what the Administration claims it’s legislative / regulatory proposals will do for health care, and what they actually do after they’ve taken effect.
Big Pharma: The Fool’s Gold that Heals_New Book
Big Pharma by Jacky Law reveals that in essence, most of the pharmaceutical industry’s claims are false; it is not the drug, but the placebo effect whose potency deserves almost all of the credit for any health improvement:
FDA Plan Would Aid Drug Makers in Liability Suits
FDA political appointees have embarked on a plan to divest the American consumer of the right to seek compensation for defective prescription drugs.
STOP the Mental Health-Child Psychiatry Industry From Diverting Public Funds
Internal e-mail exhorts university staff to lobby Congress for increased funds to increase number of children declared mentally ill.
S. Finance Committee Investigates Drug Makers Over Medical Education Grants_NYT
The Senate Finance committee is cracking down on drug industry "educational grants" to physicians, medical associations and "patient advocacy" groups.
FDA Weakens Rules on Testing New Drugs_LA Times
FDA is speeding the testing of unknown, potentially toxic products in humans (Phase I trials) without adequate pre-human tests.
Psych drug Rx for teens surge 250% over seven years_Brandeis
A Brandeis University study reviewed clinical practice (doctor office visits) and found that drug prescriptions for the treatment of depression, anxiety and mood or attention disorders in teenagers (14 to 18) increased by 250% between 1994-2001.
Cloning Scam: Dr. Gerald Schatten’s Hand in Bogus Paper Detailed
In this era of commercially-driven medical research—whether conducted by industry or academia—it behooves journal editors—no matter how prestigious the authors submitting articles for publication—to at least follow Ronald Reagan’s dictum, “trust but verify.”
FDA rules aim to speed drug tests and trim costs
The Food and Drug Administration yesterday issued new guidelines that make it easier for scientists working in universities and small companies to test promising therapies in humans without matching the hefty spending of large drug companies.